login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
Sunesis Pharmaceutic (SNSS) Stock News
USA
- NASDAQ:SNSS -
5.32
+1.04 (+24.3%)
Last: 2/24/2021, 8:00:01 PM
4.8
-0.52 (-9.77%)
After Hours:
2/24/2021, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
SNSS Latest News, Press Relases and Analysis
All
Press Releases
5 years ago - By: Benzinga
- Mentions:
ONVO
JVA
KURA
SYPR
...
80 Biggest Movers From Yesterday
5 years ago - By: Benzinga
- Mentions:
CCRN
DYNT
BKD
OPRX
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
5 years ago - By: Viracta Therapeutics, Inc.
Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement
5 years ago - By: InvestorPlace
SNSS Stock: Why Sunesis Pharmaceuticals Is Soaring Today
5 years ago - By: PennyStocks.com
- Mentions:
CTIB
CSCW
Best Penny Stocks To Buy Now As Markets Turn Lower? 3 To Watch
5 years ago - By: Viracta Therapeutics, Inc.
Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering the Use of its Combination Product Candidate for the Treatment of Epstein-Barr Virus-associated Lymphoma
5 years ago - By: Viracta Therapeutics, Inc.
Viracta Therapeutics to Participate in Upcoming Virtual Investor Conferences
5 years ago - By: PennyStocks.com
- Mentions:
IBB
IWM
VERO
OCGN
Best Penny Stocks To Buy Now? 3 Biotech Stocks To Watch In January
5 years ago - By: Kahn Swick & Foti, LLC
SUNESIS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Sunesis Pharmaceuticals, Inc. - SNSS
Please enable JavaScript to continue using this application.